News Heater
  • Home
  • Stock Ideas
    • Morning Brief
    • Analyst Insight
    • Equity Research
  • About Newsheater
    • Authors
    • Contact Us
  • Privacy Policy
No Result
View All Result
  • Home
  • Stock Ideas
    • Morning Brief
    • Analyst Insight
    • Equity Research
  • About Newsheater
    • Authors
    • Contact Us
  • Privacy Policy
News Heater
No Result
View All Result
Home Hot Stocks

Here’s Our Rant About Accuray Incorporated (ARAY)

by Denise Gardner
October 5, 2020
in Hot Stocks
0
Share on FacebookShare on Twitter

Accuray Incorporated (NASDAQ:ARAY) went up by 0.79% from its latest closing price compared to the recent 1-year high of $4.68. The company’s stock price has collected 10.87% of gains in the last five trading sessions. Press Release reported on 09/17/20 that Accuray Radixact(R) System with Synchrony(R) Technology Delivers Advanced Cancer Treatments at Multiple Hospitals in Japan

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is It Worth Investing in Accuray Incorporated (NASDAQ :ARAY) Right Now?

Accuray Incorporated (NASDAQ:ARAY) scored a price-to-earnings ratio above its average ratio, recording 63.75 x from its present earnings ratio. Plus, the 36-month beta value for ARAY is at 1.89. Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for Accuray Incorporated declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

Related articles

Is Cemtrex Inc. (CETX) a Keeper?

January 25, 2021

A Lesson to Learn: Merck & Co. Inc. (MRK)

January 25, 2021

The average price from analysts is $7.00. ARAY currently public float of 87.30M and currently shorts hold a 3.89% ratio of that float. Today, the average trading volume of ARAY was 602.87K shares.

ARAY’s Market Performance

ARAY stocks went up by 10.87% for the week, with a monthly jump of 10.87% and a quarterly performance of 16.97%, while its annual performance rate touched -5.20%. The volatility ratio for the week stands at 7.60% while the volatility levels for the past 30 days are set at 6.61% for Accuray Incorporated. The simple moving average for the period of the last 20 days is 7.99% for ARAY stocks with a simple moving average of 4.03% for the last 200 days.

Analysts’ Opinion of ARAY

Many brokerage firms have already submitted their reports for ARAY stocks, with BTIG Research repeating the rating for ARAY by listing it as a “Buy.” The predicted price for ARAY in the upcoming period, according to BTIG Research is $9.50 based on the research report published on January 21st of the current year 2020.

ARAY Trading at 6.44% from the 50-Day Moving Average

After a stumble in the market that brought ARAY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -45.51% of loss for the given period.

Volatility was left at 6.61%, however, over the last 30 days, the volatility rate increased by 7.60%, as shares surge +12.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.87% upper at present.

During the last 5 trading sessions, ARAY rose by +10.87%, which changed the moving average for the period of 200-days by -7.94% in comparison to the 20-day moving average, which settled at $2.38. In addition, Accuray Incorporated saw -9.57% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ARAY starting from Hamamatsu Shigeyuki, who sale 10,563 shares at the price of $2.70 back on Jan 03. After this action, Hamamatsu Shigeyuki now owns 185,644 shares of Accuray Incorporated, valued at $28,523 using the latest closing price.

Chew Jesse, the SVP, General Counsel of Accuray Incorporated, sale 601 shares at $2.74 during a trade that took place back on Dec 04, which means that Chew Jesse is holding 89,176 shares at $1,647 based on the most recent closing price.

Stock Fundamentals for ARAY

Current profitability levels for the company are sitting at:

  • +3.56 for the present operating margin
  • +39.10 for the gross margin

The net margin for Accuray Incorporated stands at +1.00. The total capital return value is set at 5.51, while invested capital returns managed to touch 1.57. Equity return is now at value 6.90, with 0.80 for asset returns.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Based on Accuray Incorporated (ARAY), the company’s capital structure generated 348.40 points at debt to equity in total, while total debt to capital is 77.70. Total debt to assets is 45.16, with long-term debt to equity ratio resting at 335.48. Finally, the long-term debt to capital ratio is 74.82.

Currently, EBITDA for the company is 6.52M with total debt to EBITDA at 8.94. When we switch over and look at the enterprise to sales, we see a ratio of 0.78, with the company’s debt to enterprise value settled at 0.75. The receivables turnover for the company is 3.77 and the total asset turnover is 0.82. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.95.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Tags: Accuray IncorporatedARAYARAY stockNASDAQ:ARAY
Share76Tweet47

Related Posts

Is Cemtrex Inc. (CETX) a Keeper?

by Melissa Arnold
January 25, 2021
0

Cemtrex Inc. (NASDAQ:CETX) went up by 12.80% from its latest closing price compared to the recent 1-year high of $3.75....

A Lesson to Learn: Merck & Co. Inc. (MRK)

by Nicola Day
January 25, 2021
0

Merck & Co. Inc. (NYSE:MRK) went down by -0.25% from its latest closing price compared to the recent 1-year high...

Load More
  • Trending
  • Comments
  • Latest

Business Model Helped NIO Stock Add 11 Times To Its Value This Year

November 13, 2020

Celsion Corporation (CLSN) Reveals an Earnings Mystery

January 20, 2021

Zosano Pharma Corporation (ZSAN) upgraded Issued by Wall Street Gurus

January 20, 2021

Brickell Biotech Inc. (BBI) upgraded Issued by Wall Street Gurus

January 21, 2021

4 Stocks to Watch Today…

0

A $2 5G Picks and Shovels Company with Bullish Momentum…

0

These 4 Stocks are ready to move!

0

4 Stocks to Watch on Tuesday…

0

Predictive Oncology Inc. (POAI): Skating on Thin Ice? We Know the Answer

January 25, 2021

Is Cemtrex Inc. (CETX) a Keeper?

January 25, 2021

Why LM Funding America Inc. (LMFA)’s Most Recent Report Reveals Some Hints About Its Future

January 25, 2021

MoneyGram International Inc. (MGI) Reveals an Earnings Mystery

January 25, 2021

News Heater

News Heater is specialized on the investments in tech sphere. Its specialists are interested in stocks that have been undervalued by different reasons. They are trying to find them, count their potential and bring them to their clients.

Categories

  • Analyst Insight
  • Business
  • Companies
  • Equity Research
  • Hot Stocks
  • Morning Brief
  • Stock Ideas
  • Trending
  • Uncategorized

Tags

Adamis Pharmaceuticals Corporation ADMP ADMP stock AT&T Inc. Carnival Corporation & Plc Discovery Inc. Exxon Mobil Corporation F FCX Ford Motor Company Fox Corporation F stock Inc JPM JPMorgan Chase & Co. JPM stock KDP KDP stock Keurig Dr Pepper Inc. Moderna Inc. MRNA stock NASDAQ:ADMP NASDAQ:QCOM NYSE:F NYSE:JPM NYSE:ORCL NYSE:T NYSE:WFC NYSE:XOM Oracle Corporation ORCL PFE stock QCOM QCOM stock QUALCOMM Incorporated T T stock UBER Under Armour Inc. WFC WFC stock WTI XOM XOM stock Zillow Group Inc.

Newsletter

Coming Soon

  • Home
  • About Newsheater
  • Privacy Policy
  • Contact Us

© 2021 Newsheater

No Result
View All Result
  • Homepages
  • Business

© 2020 Newsheater.com

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

236632
236633
236634